News

Molina Healthcare (NYSE:MOH) plans to significantly scale back its Affordable Care Act business from 2027. The company intends to limit ACA operations to six states and reduce premiums by a meaningful margin. The move follows ongoing pressure on ACA profitability, including falling membership and higher medical costs. Molina Healthcare, trading at $197.55, is restructuring its portfolio as it responds to challenges in the ACA segment. The stock is up 10.7% year to date and 19.7% over the...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Molina Healthcare (NYSE:MOH) reported second-quarter 2026 adjusted earnings per share of $1.51 on $10.2 billion of premium revenue, with management pointing to steady Medicaid performance and stronger-than-expected Medicare duals results while acknowledging continued pressure in its Marketplace busi

Molina Healthcare Inc (MOH) reports robust earnings and revenue growth, but faces hurdles in its Marketplace segment and regulatory pressures.

Moby summary of Molina Healthcare, Inc.'s Q2 2026 earnings call

Molina Healthcare (NYSE:MOH) shares dropped more than 9% in premarket trading on Thursday after the health insurer issued a full-year revenue outlook that disappointed investors, despite reporting second-quarter earnings ahead of market expectations. While profitability exceeded forecasts, concerns over slowing revenue growth and ongoing Medicaid headwinds weighed heavily on market sentiment.

The headline numbers for Molina (MOH) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

By Padmanabhan Ananthan July 22 (Reuters) - Molina Healthcare raised its annual profit forecast on Wednesday after posting second-quarter profit and revenue that beat Wall Street estimates, helped by

Molina (MOH) delivered earnings and revenue surprises of +10.22% and -0.08%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

The insurance company, which primarily operates through Medicare and Medicaid, said net income fell to $60 million due to lower premium revenue and an increase in the medical care ratio.

Molina healthcare has seen its stock edge down in recent days amid concerns about Medicaid cost pressures.

Beyond analysts' top-and-bottom-line estimates for Molina (MOH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.

Healthcare insurance company Molina Healthcare (NYSE:MOH) will be reporting results this Wednesday after market close. Here’s what investors should know.

Molina Healthcare stock has climbed over the past year and recently touched a 52 week high after winning a large Illinois Medicaid contract, yet its valuation checks still lean expensive and the long term share price record over three years is weak. For investors, that mix of recent enthusiasm and a low value score raises the question of whether the current price already builds in much of the good news. Over the past three years, Molina Healthcare shares have declined 29.2%, which contrasts...

MOH faces lower Marketplace revenues and membership ahead of Q2 results, while Medicaid and Medicare premium growth may offset some pressure.

The core narrative surrounding UnitedHealth Group (UNH) is dominated by its successful margin recovery, yet the underlying data reveal a shift from a growth compounder to a vulnerable margin defender. The defining insight is not the massive bottom-line beat of a $6.38 adjusted earnings per share against a $4.94 consensus estimate. Rather, it is the deliberate contraction of the core membership base to support margins in the face of significant regulatory headwinds.

Elevance Health topped Q2 earnings estimates Wednesday, despite falling medical membership, but profit was boosted by one-time "below-the-line" factors and the full-year outlook was underwhelming. ELV stock tumbled, making it among the S&P 500's early laggards. Molina Healthcare, another S&P 500 managed care stock, joined Elevance among the biggest laggards performers in pre-market trading.

Centene secures a four-year Illinois Medicaid contract renewal, preserving a key membership base and reinforcing long-term revenue stability.

CNC is turning operational improvements into margin gains, with stronger cost controls and AI-driven tools supporting profitability. Can the momentum continue?

Alignment Healthcare is using AI automation, quality plans and complex-care growth to improve Medicare Advantage economics while cost and rule pressures remain.

In late June 2026, Molina Healthcare, Inc. (NYSE:MOH) was removed from several Russell growth and defensive indices while being added to the Russell 2500 Index and Russell 2500 Value Benchmark. This reshuffling marks a shift in how index providers classify Molina, highlighting a tilt toward smaller-cap, value-oriented healthcare exposure after a weaker quarter. We’ll now examine how Molina’s reclassification into value-oriented indices could influence its existing investment narrative and...

Alignment Healthcare's Medicare Advantage growth, quality ratings and automation gains are lifting profitability, but 2026 execution risks remain.

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including Molina Healthcare (NYSE:MOH) and its peers.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 12.4% gain over the past six months, beating the S&P 500 by 5.6 percentage points.

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Joel Greenblatt's Magic Formula flags Peabody Energy, Molina Healthcare, and H&R Block as cheap businesses worth owning, but cheap and high-quality still fails retirement investors if the income dries up when markets turn ugly.

Molina Healthcare (MOH) has a clear path to earnings growth through 2027, supported by the reversal

Before Michael Burry shut down Scion Asset Management in late 2025 and pivoted to publishing a Substack newsletter warning of an “AI Bubble,” his final 13F filings reportedly disclosed put options against NVIDIA (NASDAQ:NVDA) and Palantir (NASDAQ:PLTR) alongside a heavy rotation, around 51% of the disclosed portfolio, into health insurer Molina Healthcare. That is the documented record, a snapshot ... Michael Burry Called the 2008 Crash. Now He’s Shorting Nvidia to Buy This Boring Healthcare Sto